UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 5.920

Sortiert nach

Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus

HLA, 2016-10, Vol.88 (4), p.187-193

2016

Link zum Volltext

Verfügbarkeit prüfen

Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study

Scientific reports, 2016-12, Vol.6 (1), p.38262-38262, Article 38262

2016

Link zum Volltext

Verfügbarkeit prüfen

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma

European journal of cancer (1990), 2010-06, Vol.46 (9), p.1640-1649

2010

Link zum Volltext

Verfügbarkeit prüfen

Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas

Clinical cancer research, 2017-07, Vol.23 (14), p.3884-3895

2017

Link zum Volltext

Verfügbarkeit prüfen

Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma

Experimental oncology, 2020-06, Vol.42 (2), p.115

2020

Link zum Volltext

Verfügbarkeit prüfen

Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population

PloS one, 2013-11, Vol.8 (11), p.e80570

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection

Annals of oncology, 2011-10, Vol.22 (10), p.2257-2266

2011

Link zum Volltext

Verfügbarkeit prüfen

Association of single nucleotide polymorphism in hsa-miR-499 and hsa-miR-196a2 with the risk of prostate cancer

International urology and nephrology, 2019-05, Vol.51 (5), p.811-816

2019

Link zum Volltext

Verfügbarkeit prüfen

Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer

Cellular physiology and biochemistry, 2015-01, Vol.37 (4), p.1454-1462

2015

Link zum Volltext

Verfügbarkeit prüfen

A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE

PloS one, 2019-05, Vol.14 (5), p.e0216736

2019

Link zum Volltext

Verfügbarkeit prüfen

Immunochemical studies on HNE-modified HSA: Anti-HNE–HSA antibodies as a probe for HNE damaged albumin in SLE

International journal of biological macromolecules, 2016-05, Vol.86, p.145-154

2016

Link zum Volltext

Verfügbarkeit prüfen

Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis

Medical science monitor, 2020-03, Vol.26, p.e920478-e920478

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation for histology‐driven diagnosis in non‐small cell lung cancer using hsa‐miR‐205 and hsa‐miR‐21 expression by two different normalization strategies

International journal of cancer, 2016-02, Vol.138 (3), p.689-697

2016

Link zum Volltext

Verfügbarkeit prüfen

Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing

International journal of cancer, 2020-01, Vol.146 (2), p.521-530

2020

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2030-2037

2009

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic circular RNA Hsa‐circ‐000684 interacts with microRNA‐186 to upregulate ZEB1 in gastric cancer

The FASEB journal, 2020-06, Vol.34 (6), p.8187-8203

2020

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA hsa‐let‐7b suppresses the odonto/osteogenic differentiation capacity of stem cells from apical papilla by targeting MMP1

Journal of cellular biochemistry, 2018-08, Vol.119 (8), p.6545-6554

2018

Link zum Volltext

Verfügbarkeit prüfen

Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer

Cancer biomarkers : section A of Disease markers, 2024, Vol.39 (4), p.313

2024

Link zum Volltext

Verfügbarkeit prüfen

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Cancer, 2010-05, Vol.116 (9), p.2148-2158

2010

Link zum Volltext

Verfügbarkeit prüfen

Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders

Disease markers, 2022, Vol.2022, p.3004338-12

2022

Link zum Volltext

Verfügbarkeit prüfen

hsa‑miR‑15a‑5p inhibits colon cell carcinoma via targeting CCND1

Molecular medicine reports, 2021-10, Vol.24 (4), Article 735

2021

Link zum Volltext

Verfügbarkeit prüfen

Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer

Molecular medicine reports, 2021-06, Vol.23 (6), Article 421

2021

Link zum Volltext

Verfügbarkeit prüfen

Epigenetic inactivation of the hsa‐miR‐203 in haematological malignancies

Journal of cellular and molecular medicine, 2011-12, Vol.15 (12), p.2760-2767

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung

Tumor biology, 2017-10, Vol.39 (10), p.1010428317728417-1010428317728417

2017

Link zum Volltext

Verfügbarkeit prüfen

Estrogen‐Induced hsa‐miR‐10b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1

Arthritis & rheumatology (Hoboken, N.J.), 2021-11, Vol.73 (11), p.2052-2058

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 5.920

Suche als RSS-Feed

Aktive Filter

KollektionFactiva

ThemaAdult

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.515)
Mit Volltextzugriff
(5.350)

Publikationsform

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.919)
EZB Electronic Journals Library
(3.405)
IngentaConnect Journals
(3.012)
RCN full-text journals@Ovid
(2.700)
IngentaConnect Journals
(1.960)
Wiley Online Library Journals
(1.298)
Springer journals
(1.119)
Wiley Online Library Full Collection 2018
(1.003)
Elsevier ScienceDirect Journals Complete
(795)
Single Journals
(763)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(635)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(544)
Nature Journals
(455)
Oxford University Press Journals Current
(247)
Taylor & Francis Current Content Access
(243)
Taylor & Francis Journals Complete
(225)
Nexis Uni
(197)
SAGE Complete
(196)
Oxford Journals 2020 Medicine
(159)
Applied Social Sciences Index & Abstracts (ASSIA)
(105)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(48)
... seit 30 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Circulating hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus

Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study

The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma

Role of Host miRNA Hsa-miR-139-3p in HPV-16-Induced Carcinomas

Expression of micro-RNA hsa-miR-30c-5p and hsa-miR-138-1 in renal cell carcinoma

Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population

Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection

Association of single nucleotide polymorphism in hsa-miR-499 and hsa-miR-196a2 with the risk of prostate cancer

Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer

A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE

Immunochemical studies on HNE-modified HSA: Anti-HNE–HSA antibodies as a probe for HNE damaged albumin in SLE

Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis

Validation for histology‐driven diagnosis in non‐small cell lung cancer using hsa‐miR‐205 and hsa‐miR‐21 expression by two different normalization strategies

Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

Oncogenic circular RNA Hsa‐circ‐000684 interacts with microRNA‐186 to upregulate ZEB1 in gastric cancer

MicroRNA hsa‐let‐7b suppresses the odonto/osteogenic differentiation capacity of stem cells from apical papilla by targeting MMP1

Involvement of FAM170B-AS1, hsa-miR-1202, and hsa-miR-146a-5p in breast cancer

hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer

Circulating hsa-let-7e-5p and hsa-miR-125a-5p as Possible Biomarkers in the Diagnosis of Major Depression and Bipolar Disorders

hsa‑miR‑15a‑5p inhibits colon cell carcinoma via targeting CCND1

Hsa‑circRNA‑G004213 promotes cisplatin sensitivity by regulating miR‑513b‑5p/PRPF39 in liver cancer

Epigenetic inactivation of the hsa‐miR‐203 in haematological malignancies

Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung

Estrogen‐Induced hsa‐miR‐10b‐5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down‐Regulates Serine/Arginine‐Rich Splicing Factor 1

Aktive Filter

Suchergebnisse filtern